Outcome

Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity

Retrieved on: 
Sunday, April 7, 2024
Uric acid, Urinary tract infection, Anaphylaxis, Myocardial infarction, Common, Bronchitis, Patient, Atherosclerosis, FAHA, Cleveland Clinic, Bempedoic acid, Ezetimibe, Therapy, Anemia, Pain, MACE, Sinusitis, ACC, FOMA, FNLA, FACC, Obesity, Cardiovascular disease, Esperion Therapeutics, Abdominal pain, Risk, Gout, Spasm, Woman, American College, Body mass index, ESPR, Back pain, Outcome, ATP, Safety, Fatigue, Arthralgia, ANN, Angioedema, Kidney, Journal, Constipation, University, Adverse event, Pregnancy, CLEAR, Rash, MPH, Rupture, FDA, Molina Healthcare, JACC, Hypersensitivity, Health, Circulatory system, Tablet, CVD, Incidence, Diarrhea, Fetus, Gallstone, Diet, Excipient, Upper respiratory tract infection, Dietary supplement

ANN ARBOR, Mich., April 07, 2024 (GLOBE NEWSWIRE) -- Esperion (Nasdaq: ESPR) today announced the presentation of results from three pre-specified subgroups from CLEAR Outcomes at the 2024 American College of Cardiology’s Annual Scientific Sessions (ACC.24): women, Hispanic/Latinx, and patients with obesity. These results align with the American College of Cardiology’s robust diversity, equity and inclusion programs to drive cultural change across the profession and ensure that the cardiovascular care team is as diverse as the patients they care for and that all patients are represented in cardiovascular research. The data also reinforce the mission of the ACC: transforming cardiovascular care for all.

Key Points: 
  • “Bempedoic acid is the only FDA approved non-statin LDL lowering therapy to demonstrate reductions in MACE in both primary prevention and secondary prevention patient populations.
  • The Hispanic population is the largest ethnic minority in the U.S., yet is a population historically underrepresented in clinical trials.
  • At Esperion, we discover, develop, and commercialize innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases.
  • CLEAR Outcomes is part of the CLEAR clinical research program for NEXLETOL® (bempedoic acid) Tablet and NEXLIZET® (bempedoic acid and ezetimibe) Tablet.

Florida Cancer Specialists & Research Institute Shares Pharmacy Expertise To Advance Medically Integrated Oncology Care

Retrieved on: 
Wednesday, April 3, 2024
Real-World Evidence, RN, Success, BP, RRMM, Doctor of Pharmacy, BCPS, Selinexor, Incidence, Partnership, Physician, Manufacturing, Bachelor of Pharmacy, DNP, Nursing, Prior authorization, Pharmacist, Roger Hawkins (drummer), CAPM, MPA, BSN, Therapy, RPH, Pharmacy, Outcome, Safety, Infrared spectroscopy correlation table, Best practice, FCS, PACS, OCN, Data, Metric, Health care

FORT MYERS, Fla., April 3, 2024 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) leaders and pharmacy experts will share insights and best practices in specialty pharmacy operations and dispensing that are contributing to positive patient outcomes at the NCODA 2024 Spring Forum in Dallas. The focus of the multi-day gathering, "Driving Optimal Strategies for Patient Care in Medically Integrated Oncology," is on the vital role of pharmacy involvement throughout the entire cancer care continuum.

Key Points: 
  • The focus of the multi-day gathering, "Driving Optimal Strategies for Patient Care in Medically Integrated Oncology," is on the vital role of pharmacy involvement throughout the entire cancer care continuum.
  • "Our Rx To Go team members continue to set the standard of excellence for medically-integrated oncology pharmacy and support services," said FCS President & Managing Physician Lucio Gordan, MD .
  • "They are well-equipped to contribute top-tier knowledge to help steer the future of oncology care."
  • NCODA is a globally recognized not-for-profit organization dedicated to building a patient-centered, medically integrated community of health care providers whose focus is to innovate the continuity of cancer care so that every patient receives the maximum benefit from their cancer treatment.

Circadia Health, Cleveland Clinic Research Collaboration Shows Predictive Power of Continuous Respiratory Monitoring in Prediction of Clinical Deterioration in COVID-19

Retrieved on: 
Wednesday, March 13, 2024
Research, COVID-19, Vital signs, Respiratory rate, Patient, C100, University, SARS-CoV-2, Infection, Cleveland Clinic, Outcome, LOS, FDA, Outcomes research, Health, Frontiers in Medicine

LOS ANGELES, March 13, 2024 /PRNewswire-PRWeb/ -- Continuous monitoring of respiratory rate of patients admitted with Covid-19 using contactless technology demonstrates the ability to predict those at high risk of clinical deterioration up to 24 hours in advance, in a study recently published in Frontiers in Medicine (https://doi.org/10.3389/fmed.2023.1243050).

Key Points: 
  • The study, conducted in collaboration with the Cleveland Clinic, demonstrates Circadia Health's C100 system's ability to offer continuous, contactless respiratory monitoring, predicting clinical deterioration 24 hours in advance and enhancing patient care.
  • In a landmark study, a collaboration between Circadia Health, Cleveland Clinic, and the University of Barcelona utilised the Circadia Health C100 system to monitor patients with respiratory symptoms of SARS-CoV-2 (COVID-19) severe enough to warrant admission to hospital.
  • The C100 system provides continuous respiratory rate monitoring without the need for patient contact, providing respiratory rate data every three seconds.
  • The standard vital sign relating to respiratory function, intermittent respiratory rate measurement, was not predictive of subsequent decline.

Itron Acquires Elpis Squared, Expands Grid Edge Intelligence Portfolio

Retrieved on: 
Tuesday, March 5, 2024
Environment, Technology, Utilities, Software, Alternative Energy, Green Technology, Other Natural Resources, Energy, Data Management, Natural Resources, Acquisition, Engineering, Anomaly, Investment, Outcome, Public utility, Intelligence, Life, Carbon, ITRI, City, Water, Renewable energy

The acquisition will strengthen and complement Itron’s solutions, adding expertise in grid planning, operations and engineering to Itron’s Grid Edge Intelligence portfolio.

Key Points: 
  • The acquisition will strengthen and complement Itron’s solutions, adding expertise in grid planning, operations and engineering to Itron’s Grid Edge Intelligence portfolio.
  • The acquisition of Elpis Squared allows Itron to embed real-time, high-resolution grid edge data into the grid planning, operations and engineering process – an industry first.
  • “The acquisition of Elpis Squared strengthens Itron’s Grid Edge Intelligence portfolio and will accelerate our product roadmap to create more value for our customers,” said Don Reeves, senior vice president of Outcomes at Itron.
  • Integrated solutions with Itron’s Grid Edge Intelligence portfolio are expected to be available in Q4 2024.

Itron Introduces Distributed Intelligence Enabled Applications to Optimize Capacity at the Grid Edge

Retrieved on: 
Tuesday, February 27, 2024
Environment, Technology, Utilities, Software, Alternative Energy, Green Technology, Other Natural Resources, Energy, Hardware, Natural Resources, TECO Energy, Location awareness, EV, AMI, Intelligence, API, Outcome, Public utility, City, Life, ITRI, OT, Water, Renewable energy

These distributed intelligence (DI)-enabled, first-of-its-kind applications are part of Itron’s Grid Edge Intelligence portfolio.

Key Points: 
  • These distributed intelligence (DI)-enabled, first-of-its-kind applications are part of Itron’s Grid Edge Intelligence portfolio.
  • Low-Voltage Grid Insights: Increased awareness of how distributed energy resources impact the grid in near real time to help improve grid efficiencies.
  • This will help us to ensure our solar generation and deployment improves grid efficiencies.”
    “Without the right tools, it can be difficult to optimize capacity at the grid edge.
  • With our DI solution, utilities can optimize capacity at the edge of the grid efficiently and cost effectively.

Exabeam Introduces Transformative Unified Workbench for Security Analysts with Generative AI Assistance

Retrieved on: 
Tuesday, February 27, 2024
Software, Networks, Internet, Artificial Intelligence, Data Management, Technology, Other Technology, Security, Sentinel, Collector, AI, Investment, Outcome, IBM, Learning, Communication, VyStar Credit Union, API, Organization, SA Power Networks, Automation, Logic, Microsoft, SOC, Workflow, Risk management

Exabeam , a global cybersecurity leader that delivers AI-driven security operations, today announced two pioneering cybersecurity features, Threat Center and Exabeam Copilot, to its market leading AI-driven Exabeam Security Operations Platform.

Key Points: 
  • Exabeam , a global cybersecurity leader that delivers AI-driven security operations, today announced two pioneering cybersecurity features, Threat Center and Exabeam Copilot, to its market leading AI-driven Exabeam Security Operations Platform.
  • A first-to-market combination, Threat Center is a unified workbench for threat detection, investigation, and response (TDIR) that simplifies and centralizes security analyst workflows, while Exabeam Copilot uses generative AI to help analysts quickly understand active threats and offers best practices for rapid response.
  • With Threat Center and Exabeam Copilot, the Exabeam Security Operations Platform applies AI and automation to security operations workflows for a holistic approach to cyberthreats, helping companies solve for a lack of automation and ultimately accelerating response.
  • Powered by an advanced security-trained, generative AI model, Exabeam Copilot supercharges security analyst investigations.

Itron Announces Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Monday, February 26, 2024
Other Energy, Utilities, Hardware, Other Natural Resources, Sustainability, Alternative Energy, IOT (Internet of Things), Energy, Technology, Natural Resources, Environment, Green Technology, Other Technology, Acquisition, Total, Intelligence, Interest, Outcome, EST, Sale, Water resources, ITRI, GAAP, City, Webcast, Automation, EPS, Water, Cryptocurrency

Itron, Inc. (NASDAQ:ITRI), which is innovating new ways for utilities and cities to manage energy and water, announced financial results for its fourth quarter and full year ended Dec. 31, 2023.

Key Points: 
  • Itron, Inc. (NASDAQ:ITRI), which is innovating new ways for utilities and cities to manage energy and water, announced financial results for its fourth quarter and full year ended Dec. 31, 2023.
  • Our solutions address this complexity head on and support our customers' efforts to modernize critical infrastructure.”
    Total fourth quarter revenue increased 23%, to $577 million.
  • After bookings of $839 million during the fourth quarter, total backlog at quarter end was $4.5 billion.
  • First quarter 2024 financial outlook:
    Full year 2024 financial guidance:
    Itron will host a conference call to discuss the financial results contained in this release at 10 a.m. EST on February 26, 2024.

Itron and The Mobility House to Address Grid Constraints with First-of-its-Kind EV Fleet Electrification Program

Retrieved on: 
Friday, February 23, 2024
Green Technology, Fleet Management, Vehicle Technology, Environment, Batteries, Automotive, EV, Electric Vehicles, Software, Networks, Hardware, Data Management, Technology, Other Natural Resources, Utilities, Alternative Vehicles, Fuels, Alternative Energy, Natural Resources, Energy, Multimedia, Intelligence, Forecasting, Outcome, Transport, ITRI, FIX, City, Fast, Mathematical optimization, Electricity, Mobility, Water, Renewable energy

The first-of-its-kind program is designed to help utilities and grid operators address interconnection delays and infrastructure challenges associated with EV fleet electrification.

Key Points: 
  • The first-of-its-kind program is designed to help utilities and grid operators address interconnection delays and infrastructure challenges associated with EV fleet electrification.
  • With FIX, transportation electrification goals are achieved more quickly and at lower costs than traditional methods of distribution load assessments and infrastructure upgrades.
  • “As a result of widespread EV fleet adoption, utilities and grid operators are facing greater complexity related to grid preparedness,” said Don Reeves, senior vice president of Outcomes at Itron.
  • For more information, visit Itron’s booth #2200 at DISTRIBUTECH International from Feb. 27-29, 2024, in Orlando, Florida, or visit Itron’s EV Charging Management solution page .

Itron and Schneider Electric Join Forces to Modernize and Simplify Energy Distribution, Address Energy Transition

Retrieved on: 
Wednesday, February 21, 2024
Software, Internet, Other Energy, Utilities, Other Natural Resources, Data Management, Alternative Energy, Energy, Technology, Natural Resources, Environment, Green Technology, DER, Schneider Electric, Multimedia, Intelligence, Investment, Outcome, ADMS, Internet of things, Transport, Public utility, Grid, Electricity, Press, Conference, ITRI, Industrial internet of things, Heat, City, Mathematical optimization, Automation, News, GIS, Water, Wildfire, Renewable energy

In a stepwise approach, the companies will integrate their intelligent grid and distributed energy resource (DER) management solutions to digitalize the demand and supply of electricity.

Key Points: 
  • In a stepwise approach, the companies will integrate their intelligent grid and distributed energy resource (DER) management solutions to digitalize the demand and supply of electricity.
  • View the full release here: https://www.businesswire.com/news/home/20240221420542/en/
    Electricity demand is rapidly increasing due to the electrification of transportation, heating, and more.
  • With this collaboration, utilities can extend energy orchestration to behind-the-meter assets, enabling proactive management of grid constraints when and where needed.
  • Sophisticated grid edge intelligence solutions also support behind-the-meter intelligence—essential as more homes and commercial properties are equipped with DER like solar and electric vehicles.

Circuitry.ai welcomes Dr. Lorien Pratt as Decision Intelligence Advisor

Retrieved on: 
Tuesday, February 20, 2024
Professional Services, Data Management, Data Analytics, Technology, Other Technology, Software, Artificial Intelligence, DARPA, Television, Human Genome Project, AI, Outcome, TED (conference), Human, Enterprise, Administration, Machine learning, DOE, CSPAN, Decision intelligence, NPR, Medical device

"We are delighted to welcome Dr. Lorien Pratt as advisor to Circuitry.ai.

Key Points: 
  • "We are delighted to welcome Dr. Lorien Pratt as advisor to Circuitry.ai.
  • "As the inventor of decision intelligence, Dr. Pratt is unmatched in this space.
  • Dr. Pratt’s most recent DI book is "The Decision Intelligence Handbook: How Decision Intelligence connects Data, Actions, and Outcomes for a Better World."
  • "I am thrilled to be joining the Circuitry.ai leadership team as a Decision Intelligence advisor," said Dr. Lorien Pratt, "Circuitry.ai solutions are particularly important because they bring integrated, organization-wide evidence-based and data-driven decision making and AI into the enterprise.